GM-CSF, Fosfomycin and Metronidazole for Pouchitis in Ulcerative Colitis Patients After Restorative IPAA Surgery
Status:
Recruiting
Trial end date:
2023-05-01
Target enrollment:
Participant gender:
Summary
This study will examine whether the application of GM-CSF, fosfomycin and metronidazole
locally in the pouch is safe and effective in the treatment of pouchitis for patients with
ulcerative colitis, and whether treatment changes the microbiome of the pouch.